INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 43h ago
HOUSE PTR3h ago
SEC 13F3h ago
ROBINHOOD CHAIN3h ago
SEC FORM 4/Option exerciseVerified data

Dassing Steven R. reported KWR

VP, Principal Acctg. Officer · QUAKER CHEMICAL CORP · Common Stock

Side
M
Value
—
Shares
171
Price
—
Executed
Mar 15, 2026
Disclosed
Mar 17, 2026
Disclosure timeline2 days from execution to publication · legal deadline 2 business days
Mar 15 executedMar 17, 2026 disclosed

KWR · daily

Yahoo Finance chart API
▲Execution▼Disclosure●Material company filing●Other disclosed buy●Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.

Insider Score

Experimental signal
21/ 100 · ROUTINE
Methodology →
  • Transaction type0 / 20

    Option exercise — administrative, little informational value

  • Relative size+13 / 25

No reported dollar value · 52.9% of prior position

  • Filing timing0 / 15

    Disclosed 2 business days after execution (deadline: 2)

  • Historical behavior+8 / 15

    First recorded trade by this actor in this security

  • Frequency & clustering0 / 15

    No clustered activity in the dataset

  • Market events0 / 10

    No material company filing within 60 days after the trade

  • The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.

    Other disclosed activity · KWR

    ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
    9
    JP
    Johnson Christine ProcopioSVP, CSO
    KWRQUAKER CHEMICAL CORP
    Grant or award
    A—
    504 sh
    Oct 15, 2026Oct 19, 2026
    traded Oct 15, 2026
    +4dSEC FORM 4

    Evidence

    12
    BJ
    Bijlani JeewatEVP, Glob. Spec. & CGO
    KWRQUAKER CHEMICAL CORP
    Other acquisition or disposition
    J$1,072
    7 sh
    Aug 7, 2026Aug 11, 2026
    traded Aug 7, 2026
    +4dSEC FORM 4

    Evidence

    20
    CT
    Coler ThomasEVP, CFO
    KWRQUAKER CHEMICAL CORP
    Tax withholding
    F$107K
    741 sh
    Jun 15, 2026Jun 17, 2026
    traded Jun 15, 2026
    +2dSEC FORM 4

    Evidence

    9
    CT
    Coler ThomasEVP, CFO
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    68 sh
    Jun 15, 2026Jun 17, 2026
    traded Jun 15, 2026
    +2dSEC FORM 4

    Evidence

    21
    CT
    Coler ThomasEVP, CFO
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    2,352 sh
    Jun 15, 2026Jun 17, 2026
    traded Jun 15, 2026
    +2dSEC FORM 4

    Evidence

    9
    CT
    Coler ThomasEVP, CFO
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    2,352 sh
    Jun 15, 2026Jun 17, 2026
    traded Jun 15, 2026
    +2dSEC FORM 4

    Evidence

    9
    CT
    Coler ThomasEVP, CFO
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    68 sh
    Jun 15, 2026Jun 17, 2026
    traded Jun 15, 2026
    +2dSEC FORM 4

    Evidence

    9
    BN
    Bakhshi NanditaDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    18 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    BN
    Bakhshi NanditaDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    18 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    21
    BN
    Bakhshi NanditaDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    1,198 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    FL
    Foufopoulos - De Ridder LucreceDirector
    KWRQUAKER CHEMICAL CORP
    Grant or award
    A—
    975 sh
    Jun 1, 2026Jun 2, 2026
    traded Jun 1, 2026
    +1dSEC FORM 4

    Evidence

    16
    BN
    Bakhshi NanditaDirector
    KWRQUAKER CHEMICAL CORP
    Grant or award
    A$60K
    413 sh
    Jun 1, 2026Jun 2, 2026
    traded Jun 1, 2026
    +1dSEC FORM 4

    Evidence

    9
    FL
    Foufopoulos - De Ridder LucreceDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    1,198 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    21
    FL
    Foufopoulos - De Ridder LucreceDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    1,198 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    16
    FL
    Foufopoulos - De Ridder LucreceDirector
    KWRQUAKER CHEMICAL CORP
    Tax withholding
    F$52K
    365 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    FL
    Foufopoulos - De Ridder LucreceDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    18 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    FL
    Foufopoulos - De Ridder LucreceDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    18 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    BN
    Bakhshi NanditaDirector
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    1,198 sh
    May 31, 2026Jun 2, 2026
    traded May 31, 2026
    +2dSEC FORM 4

    Evidence

    9
    BN
    Bakhshi NanditaDirector
    KWRQUAKER CHEMICAL CORP
    Grant or award
    A—
    975 sh
    Jun 1, 2026Jun 2, 2026
    traded Jun 1, 2026
    +1dSEC FORM 4

    Evidence

    21
    FA
    Frodl AndreVP, R&D-Metals & Metalworking
    KWRQUAKER CHEMICAL CORP
    Option exercise
    M—
    20 sh
    Mar 15, 2026Mar 17, 2026
    traded Mar 15, 2026
    +2dSEC FORM 4

    Evidence

    Evidence

    Verified data

    Read directly from the primary public document; every field below is as reported by the filer.

    Source

    Document
    SEC Form 4
    Publisher
    U.S. Securities and Exchange Commission (EDGAR)
    Document ID
    0002079490-26-000002
    Machine-readable
    Structured copy

    Timestamps

    Event (reported)
    Mar 15, 2026
    Published
    Mar 17, 2026
    Ingested by INSIDER
    Nov 5, 04:11 UTC
    Last re-read
    Nov 5, 04:11 UTC

    Extracted facts

    Filer
    Dassing Steven R.
    Role
    VP, Principal Acctg. Officer
    Transaction
    Option exerciseAs filed: “M”
    Asset
    QUAKER CHEMICAL CORP
    Ticker
    KWR
    Shares
    171
    Execution date (reported)
    Mar 15, 2026
    Owned after transaction
    494 shares
    Days from execution to publication
    2

    What this establishes

    Dassing Steven R. filed this Form 4 reporting a option exercise of KWR on Mar 15, 2026. It became public on Mar 17, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.

    Extraction

    Method
    Form 4 XML
    Confidence
    1.00
    VP, Principal Acctg. Officer
    Dassing Steven R.cik:0002079490
    Issuer
    QUAKER CHEMICAL CORPcik:0000081362

    Revision history · 0

    No field has changed since this record was first ingested.

    Company events

    No records

    No material filings recorded for this issuer.